PINK1 And Parkin: The Mitophagy System That Removes Damaged Mitochondria

Damaged mitochondria can lose energy output, generate Reactive Oxygen Species (ROS), and send inflammatory signals when they are not removed or repaired. R

In this post, we will discuss how PINK1 stabilization recruits Parkin, how ubiquitin labeling directs autophagosome formation and lysosomal clearance, and what the pathway means for exercise, aging, neurodegeneration, and chronic fatigue.

---

What Are PINK1 And Parkin

Mitophagy is the selective form of autophagy that removes mitochondria, not the indiscriminate destruction of every mitochondrion in a cell. R

PTEN-induced putative kinase 1 (PINK1) is a mitochondrial serine/threonine kinase that detects a loss of mitochondrial quality through changes in its processing and localization. R

Parkin is an E3 ubiquitin ligase encoded by the PRKN gene that attaches ubiquitin to proteins on the mitochondrial surface. R

PINK1 and Parkin form a damage-responsive pathway that converts a damaged mitochondrion into a tagged package for autophagic disposal. R

In healthy, polarized mitochondria, PINK1 is imported and rapidly cleaved, which keeps its steady-state abundance low. R

When the mitochondrial membrane potential collapses, PINK1 processing is blocked and the uncleaved protein accumulates on the outer mitochondrial membrane (OMM). R

That stabilization step is important because the pathway is designed to distinguish a damaged mitochondrial unit from the rest of the mitochondrial network. R

Why Mitochondrial Quality Control Matters

Mitochondria produce most cellular ATP through oxidative phosphorylation, but they also participate in calcium handling, redox signaling, apoptosis, and innate immune signaling. R

A dysfunctional mitochondrion can therefore create more than an energy problem because it may increase oxidative stress, lose respiratory efficiency, and disturb signaling to the rest of the cell. R

The cell has several layers of mitochondrial quality control, including protein repair, proteasomal degradation of individual mitochondrial proteins, fission and fusion, mitochondrial biogenesis, and mitophagy. R

Mitophagy is the layer that removes an entire mitochondrial unit when local repair is no longer enough. R

This does not mean that increasing mitophagy is always beneficial because excessive or poorly timed mitochondrial clearance can reduce the available respiratory capacity of a cell. R

The useful goal is functional turnover, where damaged mitochondria are removed while new or repaired mitochondria maintain the energy supply.

PINK1 and Parkin are important for this process, but they are not the only mitophagy system because receptor-mediated pathways involving proteins such as BNIP3, NIX, and FUNDC1 can operate independently of Parkin. R

How PINK1 And Parkin Remove Damaged Mitochondria

1. Mitochondrial Damage Stabilizes PINK1

PINK1 is continuously imported into healthy mitochondria through the translocase machinery and then cleaved as part of its normal turnover. R

A fall in membrane potential interferes with this import and cleavage process, leaving full-length PINK1 exposed on the OMM. R

PINK1 accumulation is both necessary and sufficient for Parkin recruitment in the classic cellular model of this pathway. R

The pathway therefore begins with a physical change in the mitochondrion, not with a general cellular decision to destroy mitochondria at random.

2. PINK1 Phosphorylates Ubiquitin And Parkin

Once stabilized on the damaged mitochondrion, PINK1 phosphorylates ubiquitin at serine 65 and phosphorylates Parkin at the corresponding serine 65 site in its ubiquitin-like domain. R

Phosphorylated ubiquitin binds Parkin and helps unlock the autoinhibited conformation that keeps the ligase quiet in the cytosol. R

Phosphorylated Parkin and phosphorylated ubiquitin work together to produce full activation of Parkin's E3 ligase activity. R

This is a feed-forward system because a small initial ubiquitin signal can activate Parkin, and activated Parkin can create more ubiquitin substrate for PINK1 to phosphorylate. R

3. Parkin Builds A Ubiquitin Signal On The Mitochondrion

Activated Parkin ubiquitinates multiple OMM proteins, including regulators of mitochondrial movement and fusion, which helps immobilize and isolate the damaged organelle. R

The growing ubiquitin chains are not merely disposal labels because they become a signaling platform for the autophagy machinery. R

Some ubiquitinated mitochondrial proteins can be removed individually by the 26S proteasome, while broader ubiquitin labeling can direct the entire mitochondrion toward mitophagy. R

This distinction matters because mitochondrial quality control can remove a damaged component without necessarily removing the entire organelle.

4. Autophagy Receptors Recruit The Isolation Membrane

The autophagy receptors optineurin (OPTN) and nuclear dot protein 52 (NDP52) bind ubiquitin chains on the damaged mitochondrion and recruit the machinery that starts an autophagosome. R

The kinase TANK-binding kinase 1 (TBK1) phosphorylates OPTN and NDP52-associated components, which strengthens receptor retention and promotes efficient mitophagy. R

OPTN and NDP52 connect the ubiquitinated mitochondrion to autophagy initiation proteins such as ULK1, DFCP1, WIPI1, and the LC3 family. R

An isolation membrane then expands around the tagged mitochondrion and closes to form a double-membrane autophagosome. R

The autophagosome is therefore the physical container that separates the damaged mitochondrion from the rest of the cytoplasm before degradation.

5. The Autophagosome Fuses With A Lysosome

The completed autophagosome is delivered to a lysosome, where acidic hydrolases break down the mitochondrial material into components that the cell can recycle. R

This final step is why increased ubiquitination or increased LC3 signal alone cannot prove that mitophagy has been completed.

Researchers need to distinguish pathway initiation from mitophagy flux, which means that the damaged mitochondrion has actually moved through autophagosome formation and lysosomal degradation. R

Exercise And Aging

Exercise is a mitochondrial stressor, but the human evidence does not support the simple claim that every workout immediately increases PINK1 and Parkin mitophagy.

Endurance-trained runners had higher skeletal muscle markers of PINK1 and Parkin signaling than sedentary controls in one small human study, although those markers were not associated with metabolic flexibility. R

That study measured pathway-associated proteins rather than proving complete mitochondrial clearance, so it is evidence of altered signaling rather than proof of higher mitophagy flux.

In contrast, a study of seven trained athletes found that two hours of endurance exercise increased fission and some mitophagy-related transcripts but did not activate early mitophagy flux in skeletal muscle. R

The same study found that fed exercise produced more preparatory mitophagy and mitochondrial biogenesis signals than fasted exercise, which argues against treating fasting as automatically superior for mitochondrial turnover. R

A 2024 study in eight healthy men found mitophagosome-like structures after one resistance exercise session and proposed that muscle may also eject damaged mitochondrial material, but the sample was small and the study was acute and preliminary. R

The aging data are also more complicated than a single decline curve.

In mice, acute exercise-induced mitophagy was dependent on Parkin and was attenuated in aged muscle, which is animal-only evidence that aging can reduce the response to a mitochondrial stress signal. R

In Drosophila, mitophagy increased with aging in muscle and dopaminergic neurons, while PINK1 or Parkin deficiency prevented that age-dependent increase. R

In humans, physically inactive frail older women had lower expression of several autophagy and mitophagy-related genes, including PINK1 and PARKIN, than active healthy older women in a cross-sectional study. R

The practical conclusion is that regular activity may support mitochondrial turnover in people who tolerate it, but the correct dose, timing, tissue, and recovery state matter.

Neurodegeneration And Parkinson's Disease

PINK1 and PRKN became central to neurodegeneration research because pathogenic variants in both genes cause autosomal recessive early-onset Parkinson's disease. R

This genetic connection links defective mitochondrial quality control to the vulnerability of dopaminergic neurons, which have high energy requirements and long axonal projections. R

The strongest causal evidence comes from inherited forms of Parkinson's disease and from cellular and animal models, not from a finding that every person with sporadic Parkinson's disease has a simple PINK1 or Parkin deficiency. R

Only a minority of Parkinson's disease cases are classified as monogenic, and the broader disease is influenced by multiple genes, aging, environmental exposures, and tissue-specific biology. R

Impaired PINK1 or Parkin signaling can reduce the cell's ability to clear damaged mitochondria and can increase mitochondrial stress in experimental neurons. R

Phosphorylated ubiquitin at serine 65 is being investigated as a possible indicator of PINK1 pathway activity, but it is not a routine clinical test that can diagnose mitochondrial failure or predict Parkinson's disease in an individual. R

Chronic Fatigue And Post-Exertional Malaise

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) includes fatigue, cognitive symptoms, and Post-Exertional Malaise (PEM), but it should not be reduced to a single mitochondrial pathway defect.

A systematic review of mitochondrial abnormalities in ME/CFS found heterogeneous findings across tissues and methods, which is not the same as proving a uniform PINK1 or Parkin deficiency. R

More recent work supports mitochondrial dysfunction in skeletal muscle in at least a subgroup of people with ME/CFS and links muscle energy failure to exertional intolerance and PEM. R

That evidence makes mitochondrial quality control a reasonable research target, but it does not establish that forcing PINK1 or Parkin activity will treat ME/CFS.

Within Jacob's Junction Dysfunction (JD) framework, mitochondrial dysfunction is usually downstream rather than the entire root cause.

Jacob's hypothesis is that Transient Capillary Leak Syndrome (TCLS) and Micro-Sepsis (MSS) can create microvascular and inflammatory conditions that increase mitochondrial stress and make recovery harder.

That is a framework-level hypothesis, not evidence that PINK1 or Parkin is impaired in every person with chronic fatigue.

If exertion reliably triggers PEM, pushing harder to activate mitophagy is not a rational default because repeated exertion can aggravate the underlying energy deficit and muscle injury in susceptible patients. R

How To Support Mitochondrial Quality Control

The most defensible lifestyle strategy is appropriately dosed physical activity for people who can tolerate it without delayed symptom worsening. R

That sentence does not mean that people with PEM should be placed on a fixed graded exercise program because the exercise response in ME/CFS is biologically different from ordinary deconditioning. R

I would start with activity that stays inside the person's current recovery capacity and only progress when the response is stable across the following days.

Human trials of the gut-derived postbiotic urolithin A have reported improvements in some muscle endurance and mitochondrial biomarkers in older or middle-aged adults, but the trials did not establish treatment for ME/CFS or prove correction of a PINK1 or Parkin defect. R R

Urolithin A is therefore a human-studied mitophagy-related intervention, not a reason to assume that every person with fatigue needs a mitophagy activator.

For adjacent biology, I cover spermidine in the context of autophagy and longevity, MOTS-c as a mitochondrial-derived peptide, and neuropeptides, AMPK, mTOR, and autophagy as a broader signaling map.

The evidence for these adjacent approaches should not be blended together because a compound that changes autophagy, mitochondrial signaling, or exercise adaptation is not automatically a PINK1 or Parkin replacement.

What To Stay Away From

Do not treat a rise in PINK1, Parkin, LC3, or ubiquitin as proof that damaged mitochondria were cleared because pathway markers can increase before lysosomal completion. R

Do not assume that fasted exercise is superior for mitophagy because a human endurance study found that nutritional state changed the response in ways that did not support a universal fasting advantage. R

Do not push through PEM to chase a theoretical mitochondrial adaptation because ME/CFS research supports delayed metabolic and muscular consequences after exertion in at least a subgroup of patients. R

Do not assume that a supplement can replace PINK1 or Parkin when a person carries a pathogenic mutation because inherited pathway defects involve protein structure, localization, kinase activity, or ligase activity that a generic antioxidant does not automatically correct. R

Do not use unapproved research compounds or injectable peptides to force mitophagy without a clinician who can evaluate the compound, the person's diagnosis, and the potential for excessive mitochondrial stress.

Mechanisms Of Action

Simple:

• Damaged mitochondria stabilize PINK1 on their surface, which calls Parkin to the organelle. R
• Parkin adds ubiquitin tags that act like a removal signal for the autophagy machinery. R
• Autophagy receptors wrap the tagged mitochondrion in an autophagosome and deliver it to a lysosome for breakdown. R
• The cell recycles the resulting components instead of allowing a damaged energy-producing organelle to keep generating stress. R

Advanced:

• PINK1 Stabilization: Loss of membrane potential blocks PINK1 import and proteolytic processing, allowing full-length PINK1 to accumulate on the OMM and initiate damage-selective signaling. R
• Phospho-Ubiquitin Activation: PINK1 phosphorylates ubiquitin and Parkin at serine 65, and phospho-ubiquitin binds Parkin to relieve autoinhibition and increase E3 ligase activity. R R
• Ubiquitin Amplification: Activated Parkin ubiquitinates OMM substrates, generating additional phospho-ubiquitin sites that reinforce Parkin recruitment and expand the mitochondrial disposal signal. R
• Autophagy Receptor Recruitment: OPTN and NDP52 bind mitochondrial ubiquitin chains and recruit TBK1, ULK1, DFCP1, WIPI1, and LC3-associated machinery to organize local autophagosome formation. R R
• Lysosomal Completion: Autophagosome fusion with lysosomes exposes the mitochondrial cargo to acidic hydrolases, and this completed degradation step is required for true mitophagy flux. R

Genetics

PINK1

The PINK1 gene encodes a mitochondrial serine/threonine kinase that links mitochondrial membrane damage to ubiquitin phosphorylation and Parkin activation. R

Biallelic pathogenic PINK1 variants can cause autosomal recessive early-onset Parkinson's disease, often with a comparatively slow course and good levodopa response. R

A single heterozygous PINK1 variant is not automatically pathogenic, and its effect on Parkinson's disease risk depends on the specific variant and the clinical and family context. R

PRKN

The PRKN gene, historically called PARK2, encodes Parkin, an E3 ubiquitin ligase that tags damaged mitochondrial surface proteins for proteasomal or autophagic disposal. R

Biallelic pathogenic PRKN variants are a well-established cause of autosomal recessive early-onset Parkinson's disease. R

PRKN testing requires attention to exon-level deletions, duplications, and other variants that may be missed by a limited single-nucleotide panel. R

More Research

• Biomarkers: Phospho-Ser65 ubiquitin is a promising research readout of PINK1 pathway activity, but it is not yet a routine clinical biomarker for mitochondrial health. R
• Clinical Translation: The pathway was defined largely through acute mitochondrial depolarization models, so its timing and importance under ordinary human physiology remain incompletely resolved. R R
• Disease Diversity: PINK1 and PRKN explain important recessive Parkinson's disease syndromes, but sporadic neurodegeneration involves many genes and mitochondrial quality-control pathways. R R
• Interventions: Urolithin A has human randomized-trial data for muscle endurance and mitochondrial biomarkers, but those studies do not establish a treatment for neurodegeneration or ME/CFS. R R
• Physiology: Human exercise studies disagree on whether acute exercise produces immediate PINK1 and Parkin mitophagy flux, which means that intensity, feeding state, tissue, timing, and measurement method remain important variables. R R